Apokyn

FTC says patent battle over Parkinson's drug could have 'significant implications' for patients
Endpoints
Tue, 03/21/23 - 09:56 pm
FTC
Parkinson's Disease
Apokyn
Supernus Pharmaceuticals
Sage Chemical
patents